Evidence map›Paper›PMID 35185744›Full record

ArticleFrontiers in neurology2021

Remote Ischemic Conditioning in the Prevention for Stroke-Associated Pneumonia: A Pilot Randomized Controlled Trial.

Bowei Zhang, Wenbo Zhao, Hongrui Ma, Yunzhou Zhang, Ruiwen Che, Tingting Bian, Heli Yan, Jiali Xu, Lin Wang, Wantong Yu and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Remote ischaemic conditioning for preventing and treating ischaemic stroke.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Baseline neurologic deficit and efficacy of remote ischemic conditioning after acute ischemic stroke: A post hoc analysis of RICAMIS.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Bowei ZhangDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Wenbo ZhaoDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Hongrui MaDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Yunzhou ZhangDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Ruiwen CheDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Tingting BianDepartment of Neurology, Beijing Fengtai You'anmen Hospital, Beijing, China.
Heli YanDepartment of Neurology, Beijing Fengtai You'anmen Hospital, Beijing, China.
Jiali XuDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Lin WangDepartment of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Wantong YuDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Jia LiuChina-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Haiqing SongDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Jiangang DuanDepartment of Emergency, Xuanwu Hospital of Capital Medical University, Beijing, China.
Hong ChangDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Qingfeng MaDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Qian ZhangDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Xunming JiChina-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Fengtai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the continuing effort in investigating the preventive therapies for stroke-associated pneumonia (SAP), which is closely associated with unfavorable outcomes, conclusively effective therapy for the prevention of SAP is still lacking. Remote ischemic conditioning (RIC) has been proven to improve the survival in the sepsis model and inflammatory responses have been indicated as important mechanisms involved in the multi-organ protection effect of RIC. This study aimed to assess the safety and the preliminary efficacy of RIC in the prevention of SAP in patients with acute ischemic stroke.

methodsWe performed a proof-of-concept, pilot open-label randomized controlled trial. Eligible patients (age > 18 years) within 48 h after stroke onset between March 2019 and October 2019 with acute ischemic stroke were randomly allocated (1:1) to the RIC group and the control group. All participants received standard medical therapy. Patients in the RIC group underwent RIC twice daily for 6 consecutive days. The safety outcome included any adverse events associated with RIC procedures. The efficacy outcome included the incidence of SAP, changes of immunological profiles including mHLA-DR, TLR-2, and TLR-4 as well as other plasma parameters from routine blood tests.

resultsIn total, 46 patients aged 63.1 ± 12.5 years, were recruited (23 in each group). Overall, 19 patients in the RIC group and 22 patients in the control group completed this study. No severe adverse event was attributed to RIC procedures. The incidence of SAP was lower in the remote ischemic conditioning group (2 patients [10.5%]) than that in the control group (6 patients [27.3%]), but no significant difference was detected in both univariate and multivariate analysis (

interpretationThis proof-of-concept pilot randomized controlled trial was to investigate RIC as a prevention method for SAP. Remote ischemic conditioning is safe in the prevention of SAP in patients with acute ischemic stroke. The preventive effect of RIC on SAP should be further validated in future studies.

Indexed as

immune responseremote ischemic conditioning (RIC)strokestroke-associated pneumonia (SAP)stroke-induced immunodepression (SIID)

Identifiers

PMID35185744
PMCPMC8850400
OpenAlexW4210406779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.